权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Does Demethylation of the Inactive X Contribute to Lupus in Women?

非活性 X 的去甲基化是否会导致女性狼疮？

基本信息

批准号：
8398943
负责人：
BRUCE C. RICHARDSON
金额：
--
依托单位：
VETERANS HEALTH ADMINISTRATION
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-01-01 至 2014-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8398943
关键词：
Affect Animal Model Autoantibodies Autoimmune Diseases Autoimmunity B-Lymphocytes CD4 Positive T Lymphocytes CXCR3 gene Cell physiology Cells DNA DNA Methylation DNA Sequence Development Disease Epigenetic Process Estrogens Female Flare Frequencies Gene Expression Genes Gonadal Steroid Hormones Grant Human Immunoblotting Individual Klinefelter&apos s Syndrome Link Lupus Methylation MicroRNAs Military Personnel Modeling Modification Molecular Mus Pathogenesis Predisposition Prevalence Production Relative (related person)Reporting Severities Severity of illness Signal Transduction Systemic Lupus Erythematosus T-Lymphocyte TNFSF5 gene Testing Time Transcript Transfection Turner&apos s Syndrome UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferase United States Veterans Woman Work X Chromosome base chemokine receptor demethylation design effective therapy environmental agent inhibitor/antagonist insight lupus-like male men mortality new therapeutic target novel novel therapeutic intervention novel therapeutics overexpression public health relevance

项目摘要

DESCRIPTION (provided by applicant): Systemic lupus erythematosus is a sometimes fatal autoimmune disease primarily affecting women. Estrogen contributes to disease severity, but does not completely explain the female predilection. Recent reports that men with Klinefelter's Syndrome (XXY) develop lupus at the same rate as women, while women with Turner's Syndrome (XO) are protected, suggests that having 2 X chromosomes is important for disease development. However, how a second X chromosome, which is largely inactivated, contributes to lupus in women is unclear. Evidence accumulated over more than 20 years indicates that lupus develops when genetically predisposed people are exposed to environmental agents that cause DNA demethylation in T cells, and that demethylated female T cells are sufficient to cause lupus-like autoimmunity. Work from the Richardson lab has shown that the B cell costimulatory molecule CD40L, encoded on the X chromosome and known to be overexpressed on lupus T cells, is overexpressed on T cells from women but not men with lupus because the gene on the inactive female X demethylates to cause biallelic expression, while men can only transcribe from one gene. Preliminary evidence suggests that demethylated T cells from women also overexpress other X chromosome genes including the chemokine receptor CXCR3, the signaling regulator OGT, and 6 microRNAs. Based on these observations we hypothesize that demethylation of genes on the inactive X predisposes women to lupus. We will test this hypothesis by: 1. Using high throughput DNA sequencing to compare methylation of CXCR3, OGT, the 6 miRNA genes and other X chromosome genes in CD4+ T cells from healthy men and women, with and without treatment with DNA methylation inhibitors, 2. Using high throughput DNA sequencing to compare methylation of CXCR3, OGT, the 6 miRNA genes and other X chromosome genes in CD4+ T cells from men and women with lupus matched for disease activity, 3. Determining the consequences of OGT overexpression on CD4+ T cell gene expression using transfections, microarrays and immunoblotting, and identify the miRNA target transcripts using Argonaute pulldowns followed by array analyses or sequencing, and 4. Determining if overexpressing CD40L, CXCR3, OGT or X chromosome miRNAs in a recently developed murine lupus model increases the severity of lupus in males to approximate the severity in females. We anticipate that these studies will confirm that women are predisposed to lupus in part because they can overexpress more genes than men, identify the molecules responsible, and thereby identify new therapeutic targets for women with lupus.

描述（由申请人提供）：